Mechanisms underlying α-synuclein (αSyn) mediated neurodegeneration are poorly understood. Intramuscular (IM) injection of αSyn fibrils in human A53T transgenic M83 +/− mice produce a rapid model of α-synucleinopathy with highly predictable onset of motor impairment. Using varying doses of αSyn seeds, we show that αSyn-induced phenotype is largely dose-independent. We utilized the synchrony of this IM model to explore the temporal sequence of αSyn pathology, neurodegeneration and neuroinflammation. Longitudinal tracking showed that while motor neuron death and αSyn pathology occur within 2 months post IM, astrogliosis appears at a later timepoint, implying neuroinflammation is a consequence, rather than a trigger, in this prionoid model of synucleinopathy. Initiating at 3 months post IM, immune activation dominates the pathologic landscape in terminal IM-seeded M83 +/− mice, as revealed by unbiased transcriptomic analyses. Our findings provide insights into the role of neuroinflammation in αSyn mediated proteostasis and neurodegeneration, which will be key in designing potential therapies.
Introduction
Intracellular aggregates comprised of misfolded α-synuclein (αSyn) protein are neuropathological hallmarks in α-synucleinopathies, such as Parkinson's disease (PD), multiple system atrophy (MSA) and dementia with Lewy bodies (DLB) (Burre et al., 2018) . Recent findings support the idea that αSyn pathology can be induced by conformational templating of soluble αSyn into aggregates which can spread by intrasynaptic transmission (Uchihara and Giasson, 2016). Rodent experiments and in vitro studies have provided insights into unique forms of αSyn conformers that facilitate the seeding and prionoid transmission process (Uchihara and Giasson, 2016) . Although this unified hypothesis would explain both local molecular changes of αSyn as a molecular template and its stereotyped spread as a structural template, other cellular mechanisms, such as immune signaling, can be independently or synergistically involved in αSyn pathogenesis (Lim et al., 2016; Allen Reish and Standaert, 2015) .
To characterize the molecular underpinnings of prionoid transmission of αSyn pathology, we have established an experimental paradigm by injecting αSyn fibrils in the hindlimb muscles (IM) of human A53T αSyn transgenic Line M83 +/− mice. This leads to induction of synucleinopathy along the neuraxis and a highly reproducible and rapid onset of paralysis phenotype (Sacino et al., 2014) . Using this IM model, we have performed detailed temporal and spatial analysis of proteostasis onset, neurodegeneration, immune alterations and survival in mice injected with different amounts of preformed αSyn seeds. We find
